Goodman Co., Ltd
⚠️ High Risk
FEI: 3007835716 • Nagoya, Aichi • JAPAN
FEI Number
3007835716
Location
Nagoya, Aichi
Country
JAPANAddress
5f Kdx Nagoya Sakae Building, 4-5-3 Sakae, Naka-Ku, Sakae; Naka, Nagoya, Aichi, Japan
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DEVICEGMPS
The article is subject to refusal of admission pursuant to Section 801(a)(1) in that the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of Section 520(f)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) or a condition prescribed by an order under section 520(f)(2) of the FD&C Act.
DE IMP GMP
The article is subject to refusal of admission pursuant to section 801(a)(1) in that it appears that the methods used in, or the facilities or controls used for, the manufacture of the device do not conform to the applicable requirements of section 520(f).
NO PMA/PDP
The article appears to be a class III dev.w/o an approved applic. for premarket approval, and/or a notice of completion of product development protocol filed per section 515(b) or exempt per sect.520(g)(1).
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/19/2025 | 80FOZCATHETER, INTRAVASCULAR, SHORT TERM | Division of Southeast Imports (DSEI) | |
| 8/19/2025 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | Division of Southeast Imports (DSEI) | |
| 5/8/2025 | 74DQXWIRE, GUIDE, CATHETER | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 5/8/2025 | 80FOZCATHETER, INTRAVASCULAR, SHORT TERM | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 3/6/2025 | 74DQXWIRE, GUIDE, CATHETER | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 3/6/2025 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 2/25/2025 | 74DQXWIRE, GUIDE, CATHETER | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 2/25/2025 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 12/3/2024 | 74DQXWIRE, GUIDE, CATHETER | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 12/3/2024 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 8/14/2024 | 74DQXWIRE, GUIDE, CATHETER | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 8/14/2024 | 80FOZCATHETER, INTRAVASCULAR, SHORT TERM | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 1/26/2024 | 74DQXWIRE, GUIDE, CATHETER | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/26/2024 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/26/2024 | 74DQXWIRE, GUIDE, CATHETER | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/26/2024 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 3/29/2023 | 74DQXWIRE, GUIDE, CATHETER | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 3/29/2023 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/18/2023 | 74DQXWIRE, GUIDE, CATHETER | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 1/18/2023 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 12/8/2022 | 74DQXWIRE, GUIDE, CATHETER | 290DE IMP GMP | Division of Southeast Imports (DSEI) |
| 12/8/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 290DE IMP GMP | Division of Southeast Imports (DSEI) |
| 10/19/2022 | 74DQXWIRE, GUIDE, CATHETER | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 10/19/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 10/4/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 8/1/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | Division of Southeast Imports (DSEI) | |
| 7/18/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 7/18/2022 | 74DQXWIRE, GUIDE, CATHETER | 237NO PMA | Division of Southeast Imports (DSEI) |
| 7/18/2022 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 237NO PMA | Division of Southeast Imports (DSEI) |
| 7/16/2021 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | Division of Southeast Imports (DSEI) | |
| 3/9/2021 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 9/20/2019 | 74DQXWIRE, GUIDE, CATHETER | Division of Southeast Imports (DSEI) | |
| 8/15/2019 | 74DXECATHETER, EMBOLECTOMY | Division of Southeast Imports (DSEI) | |
| 8/15/2019 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | Division of Southeast Imports (DSEI) | |
| 3/8/2019 | 74DXECATHETER, EMBOLECTOMY | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 3/8/2019 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 12/21/2018 | 74DQXWIRE, GUIDE, CATHETER | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 12/21/2018 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 9/26/2018 | 74DQXWIRE, GUIDE, CATHETER | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 9/26/2018 | 74LOXCATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 8/22/2018 | 74DQXWIRE, GUIDE, CATHETER | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Goodman Co., Ltd's FDA import refusal history?
Goodman Co., Ltd (FEI: 3007835716) has 41 FDA import refusal record(s) in our database, spanning from 8/22/2018 to 8/19/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Goodman Co., Ltd's FEI number is 3007835716.
What types of violations has Goodman Co., Ltd received?
Goodman Co., Ltd has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Goodman Co., Ltd come from?
All FDA import refusal data for Goodman Co., Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.